U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182656) titled 'Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants' on Aug. 26.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of CIGB-814 for injection after single and multiple administrations in healthy participants. Secondary objectives include the assessment of preliminary pharmacodynamics (PD) and immunogenicity. Exploratory objectives are to investigate changes in immune cell subsets and signaling pathways following multiple administrations of CIGB-814.
Study Start Date: Aug. 18
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis (RA)
Interventi...